Biotech Investors & VC Firms in Europe

841 firms in this list, with a median first check of $500K. 192 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
AB Abbhi Capital Leads rounds	88🔒	Miami	US	Pre-Seed–Late Stage	—	+ Add to CRM
CU Curie.Bio AWDQABAG9 people	88🔒	Cambridge	US	Seed–Series A	$7M	+ Add to CRM
ZY Zynext Ventures MSJKVT3 people	88🔒	Pennington	US	Pre-Seed–Series B	—	+ Add to CRM
TA Talu Ventures AJJWMG3 people	88🔒	Brisbane	AU	Seed–Series A	$9.9M	+ Add to CRM
CR Crede CapitalGroup Follows rounds	88🔒	Los Angeles	US	—	$5M – $50M	+ Add to CRM
QI Qiming Venture Partners USA RB1 person · Follows rounds	88🔒	Cambridge	US	Seed–Series A	—	+ Add to CRM
EL Elmirate Capital Leads rounds	88🔒	Dubai	AE	Seed–Late Stage	$1M – $250M	+ Add to CRM
TR Trans-Pacific Technology Fund GKHLBLBC8 people	88🔒	Taipei	TW	Seed–Late Stage	—	+ Add to CRM
PE Pearls Capital MS1 person	88🔒	Doha	QA	Seed–Series A	—	+ Add to CRM
BI Bioscience Equity Partners GS1 person	88🔒	Dubai	AE	Late Stage	—	+ Add to CRM
BI Biomark Capital DLBEJZSA4 people	88🔒	Greenwich	US	Series A–Late Stage	$5M – $10M	+ Add to CRM
EX ExtraVallis Leads rounds	88🔒	Coral Gables	US	Pre-Seed–Series A	—	+ Add to CRM
FO Fosun Pharma	88🔒	Shanghai	CN	—	—	+ Add to CRM
WO Worthwhile Industries Campuses	88🔒	Toronto	CA	Late Stage	—	+ Add to CRM
MA Mankind Pharma	88🔒	New Delhi	IN	Series A	—	+ Add to CRM
PO Ponderosa Ventures TS1 person	88🔒	San Francisco	US	Pre-Seed–Series A	$100K – $750K	+ Add to CRM
EU eureKARE	88🔒	—		Seed	—	+ Add to CRM
DO Dow Venture Capital KD1 person	88🔒	Midland	US	Seed–Series A	$250K – $5M	+ Add to CRM
10 10x Genomics ASJSPCDJ4 people	88🔒	Pleasanton	US	—	—	+ Add to CRM
EP ePlanet Capital AAAJYL3 people	88🔒	San Jose	US	Seed–Late Stage	—	+ Add to CRM
MS MSD Global Health Innovation Fund	88🔒	Rahway	US	Series A–Late Stage	$1M – $30M	+ Add to CRM
BR Brandon Capital Partners CS1 person	88🔒	Melbourne	AU	Seed–Growth	—	+ Add to CRM
YO Yonjin Venture LLC DWDM2 people	88🔒	Cambridge	US	Seed–Series B	—	+ Add to CRM
PR Providence Investment Company Limited	88🔒	Germany	US	Seed–Growth	—	+ Add to CRM

Abbhi Capital

MiamiPre-Seed–Late Stage

Curie.Bio

CambridgeSeed–Series A$7M

AWDQABAG9 people

Zynext Ventures

PenningtonPre-Seed–Series B

MSJKVT3 people

Talu Ventures

BrisbaneSeed–Series A$9.9M

AJJWMG3 people

Crede CapitalGroup

Los Angeles$5M – $50M

Qiming Venture Partners USA

CambridgeSeed–Series A

RB1 person

Elmirate Capital

DubaiSeed–Late Stage$1M – $250M

Trans-Pacific Technology Fund

TaipeiSeed–Late Stage

GKHLBLBC8 people

Pearls Capital

DohaSeed–Series A

MS1 person

Bioscience Equity Partners

DubaiLate Stage

GS1 person

Biomark Capital

GreenwichSeries A–Late Stage$5M – $10M

DLBEJZSA4 people

ExtraVallis

Coral GablesPre-Seed–Series A

Fosun Pharma

Shanghai

Worthwhile Industries Campuses

TorontoLate Stage

Mankind Pharma

New DelhiSeries A

Ponderosa Ventures

San FranciscoPre-Seed–Series A$100K – $750K

TS1 person

eureKARE

Seed

Dow Venture Capital

MidlandSeed–Series A$250K – $5M

KD1 person

10x Genomics

Pleasanton

ASJSPCDJ4 people

ePlanet Capital

San JoseSeed–Late Stage

AAAJYL3 people

MSD Global Health Innovation Fund

RahwaySeries A–Late Stage$1M – $30M

Brandon Capital Partners

MelbourneSeed–Growth

CS1 person

Yonjin Venture LLC

CambridgeSeed–Series B

DWDM2 people

Providence Investment Company Limited

GermanySeed–Growth

Data sourced from public filings and firms' own websites — see our methodology.